Cannabis Stocks Rally to Best Weekly Performance of 2024
Cannabis equities surge across the board as sector momentum builds on regulatory optimism and institutional interest returning to beaten-down valuations.
Cannabis stocks are delivering their strongest weekly performance of 2024, with major operators and MSOs posting double-digit gains as investor sentiment shifts dramatically. The AdvisorShares Pure US Cannabis ETF (MSOS) has climbed over 15% this week alone, while individual names like Curaleaf Holdings and Green Thumb Industries have seen even steeper rallies. This marks a sharp reversal from the sector's prolonged bear market that has persisted since early 2021.
The rally appears driven by a confluence of factors that have cannabis investors suddenly optimistic about the sector's prospects. Renewed speculation around federal rescheduling has intensified following recent DEA commentary, while several states have advanced adult-use legalization measures that could expand addressable markets significantly. Additionally, institutional money managers have begun accumulating positions in cannabis names trading at historically low valuations, with some MSOs now valued at less than 1x revenue despite generating positive cash flows.
Technical factors are also contributing to the momentum as heavily shorted cannabis names face squeeze pressure. Short interest in major MSOs remains elevated from previous months, creating conditions for rapid price appreciation as bears cover positions. The sector's illiquidity on US exchanges amplifies these moves, with relatively modest buying volume capable of driving outsized price swings across the cannabis universe.
Despite this week's gains, cannabis stocks remain down significantly from 2021 peaks, with most names still trading 70-80% below all-time highs. The sector continues facing fundamental headwinds including limited banking access, punitive 280E tax treatment, and fragmented state-by-state regulations that constrain operational efficiency. However, improving state-level fundamentals and potential federal catalysts have created a more constructive backdrop for cannabis equities.
The sustainability of this rally depends largely on whether concrete regulatory progress materializes in coming months. Cannabis operators have demonstrated resilience during the downturn, with leading MSOs maintaining market share growth and margin expansion despite challenging operating conditions. If federal reform advances or additional states embrace legalization, the current rally could mark the beginning of a broader sector recovery rather than another false start for cannabis investors.